|

KPL-387 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 2/3: 1

Top Sponsors

  • Kiniksa Pharmaceuticals International, plc2

Indications

  • Recurrent Pericarditis2
  • Pericarditis2
  • Heart Disease2
  • Pericarditis Acute1
  • Heart Diseases1

Gilbert, Arizona1 trial

Phase 2/3 Study of KPL-387 in Recurrent Pericarditis

Investigational Site 018

Phase 2/3

Santa Monica, California1 trial

Transition to KPL-387 Monotherapy Dosing & Administration Study

Investigational Site 002

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.